3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
17
Leukemia, Myeloid, Acute
16
Leukemia
15
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
7
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hematologic Diseases
5
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Graft vs Host Disease
4
Myeloproliferative Disorders
3
Leukemia, Myeloid
3
Hematologic Neoplasms
3
Preleukemia
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphoid
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Bone Marrow Diseases
2
Blast Crisis
2
Thrombocythemia, Essential
1
Interventions
Cyclophosphamide
20
fludarabine phosphate
17
Whole-Body Irradiation
15
fludarabine
14
Melphalan
14
Tacrolimus
13
Busulfan
12
Peripheral Blood Stem Cell Transplantation
11
Mycophenolic Acid
11
Cyclosporine
6
Antilymphocyte Serum
6
Alemtuzumab
6
Methotrexate
5
Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Methylprednisolone
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
AP 1903 reagent
3
sargramostim
2
Sirolimus
2
Rituximab
2
Mesna
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Hematopoietic Stem Cell Transplantation
2
Flow Cytometry
2
Filgrastim
2
visilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Bone Marrow Transplantation
×
Myeloid
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled